Fenofibrate may reduce heart disease risk in some patients with type 2 diabetes
A new study shows that the drug fenofibrate might reduce the risk of cardiovascular events in patients with type 2 diabetes who have high levels of triglycerides and low levels of ' good ' cholesterol, despite being treated with statins.
Source: ScienceDaily Headlines - Category: Science Source Type: news
More News: Cardiology | Cardiovascular | Cholesterol | Diabetes | Diabetes Type 2 | Endocrinology | Fenofibrate | Heart | Heart Disease | Science | Statin Therapy | Study | Tricor